Photo by mykjohnson from unsplash
To investigate the risk of diabetic macular oedema (DMO) associated with the use of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM). Click to show full abstract
To investigate the risk of diabetic macular oedema (DMO) associated with the use of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM).
Keywords:
risk diabetic;
sodium glucose;
macular oedema;
diabetic macular;
type diabetes;
glucose cotransporter
Journal Title: Diabetes
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!